SS Innovations International (SSII) Operating Margin (2022 - 2026)
SS Innovations International's (SSII) quarterly Operating Margin came in at 32.78% in Q1 2026, up 8287.0% year-on-year from 0.39% in Q1 2025, and up 28.13% quarter-over-quarter from 45.6% in Q4 2025.
SS Innovations International (SSII) Operating Margin (2022 - 2026) Analysis & Trends
SS Innovations International has disclosed Operating Margin across 5 years of filings, most recently posting 32.78% for Q1 2026.
- Operating Margin for Q1 2026 came in at 32.78%, up 8287.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 24.77% (up 10438.0% YoY), and the FY2025 annual result was 19.29%, up 7261.0% from the prior year.
- Operating Margin came in at 32.78% for Q1 2026 at SS Innovations International, up from 45.6% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 0.97% in Q2 2025 to a low of 852.52% in Q4 2023.
- The 5-year median for Operating Margin is 90.93% (2024), against an average of 167.25%.
- Across the five-year window, Operating Margin tumbled 75580 bps in 2023 and soared 66329 bps in 2024, its largest moves.
- SS Innovations International's Operating Margin stood at 96.72% in 2022, then sank by 781 bps to 852.52% in 2023, then surged by 78 bps to 189.23% in 2024, then soared by 76 bps to 45.6% in 2025, then advanced by 28 bps to 32.78% in 2026.
- The last three Operating Margin figures came in at 32.78% (Q1 2026), 45.6% (Q4 2025), and 14.31% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | -32.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.78% |
| Dec 31, 2025 | -45.60% |
| Sep 30, 2025 | -14.31% |
| Jun 30, 2025 | 0.97% |
| Mar 31, 2025 | -115.65% |
| Dec 31, 2024 | -189.23% |
| Sep 30, 2024 | -73.06% |
| Jun 30, 2024 | -90.93% |
| Mar 31, 2024 | -270.29% |
| Dec 31, 2023 | -852.52% |
| Sep 30, 2023 | -84.69% |
| Jun 30, 2023 | -274.40% |
| Mar 31, 2023 | -289.27% |
| Dec 31, 2022 | -96.72% |
| Sep 30, 2022 | -80.36% |